Skip to main content
Equibles

TCG Crossover Management, LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1839948 PALO ALTO, CA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,407,573
+$1,627,144 QoQ
Shares Held
406,786
0.0% QoQ
Ownership
0.632%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#29
of 183 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TCG Crossover Management, LLC holds $3,891,479,135 across 48 Biotechnology names. CGEM ranks #43 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 6,007,834 $800,603,958
2 TNGX
Tango Therapeutics, Inc.
 9,081,201 $283,878,343
3 CGON
CG Oncology, Inc.
 3,670,206 $260,768,136
4 COGT
Cogent Biosciences, Inc.
 4,854,436 $187,866,673
5 IMVT
Immunovant, Inc.
 4,457,988 $171,766,277
6 SYRE
Spyre Therapeutics, Inc.
 1,900,582 $168,733,669
7 DNTH
Dianthus Therapeutics, Inc. /DE/
 1,676,624 $163,437,307
8 MIRM
Mirum Pharmaceuticals, Inc.
 1,062,049 $124,334,076

All Filings in CGEM

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,407,573 406,786
2026-03-31 $5,780,429 406,786